Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03399799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03399799
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-16
- Primary completion
- 2022-07-07
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.